Table 4.
Xience V | Taxus | ||
---|---|---|---|
Strut/IEL gap |
Incidence |
1/11 |
7/11 |
|
Percentage |
5.6 |
36.9 ± 32.9 |
Peri-strut hemorrhage |
Incidence |
------ |
2/11 |
|
Percentage |
------ |
11.3 ± 10.7 |
Peri-strut plasma |
Incidence |
11/11 |
3/11 |
|
Grade |
1.35 ± 20.6 |
0.78 ± 0.39 |
Marginated/subendothelial leukocytes |
Incidence |
4/11 |
10/11 |
|
Grade |
0.46 ± 0.16 |
1.00 ± 0.52 |
Neointimal neovascularization |
Incidence |
------ |
5/11 |
|
Grade |
------ |
0.80 ± 0.18 |
Medial necrosis |
Incidence |
------ |
7/11 |
|
Grade |
------ |
0.52 ± 0.26 |
Adventitial inflammation |
Incidence |
------ |
1/11 |
|
Grade |
------ |
0.33 |
Adventitial fibrosis |
Incidence |
------ |
------ |
Grade | ------ | ------ |
Incidence results are presented as # of stents with findings/total number of stents.
Mean grade or percentage results are presented as mean grade or percentage of affected struts per group ± standard deviation.
n = 11 for Xience V, n = 11 for Taxus.